Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

CAR T Cells for Treating Severe Atopic Allergic Diseases

Producción científica › revisión exhaustiva

6 Citas (Scopus)

Resumen

The prevalence of allergic diseases is rising rapdly in the US and the world. While antibody drugs and corticosteroids can provide symptom relief, they cannot cure allergic diseases. Described herein is a novel approach to treating severe atopic allergic diseases-chimeric antigen receptor-engineered T cells-that target and eliminate the cells that produce the causative agent of all atopic allergic diseases, immunoglubulin E (IgE).

Idioma originalEnglish
PublicaciónDelaware Journal of Public Health
Volumen9
N.º3
DOI
EstadoPublished - ago 2023

Huella

Profundice en los temas de investigación de 'CAR T Cells for Treating Severe Atopic Allergic Diseases'. En conjunto forman una huella única.

Citar esto